Evaluation of Fractional Ablative Laser Treatment for Skin Conditions

Inclusion criteria

• Male or female subjects aged 18-85 years
• Fitzpatrick skin type I-VI
• Has visible skin laxity in the treatment region or has a scar
• Post-menopausal or surgically sterilized, or using a medically acceptable form of birth control at least 3 months prior to enrollment and during the entire course of the study, and no plans to become pregnant for the duration of the study (Applicable to female subjects only)
• Willing to have digital imaging and measurements taken of the treatment area and agree to use for presentation, educational or marketing purposes
• Subject must be able to read, understand and sign Informed Consent Form in English
• Must be willing to adhere to the treatment and follow-up schedule and post-treatment care instructions

Exclusion criteria

• Participation in a clinical trial of another device or drug within 6 months prior to enrollment or during the study.
• Any type of prior cosmetic treatment to the target area at physicians' discretion
• History of malignant tumors in the target area.
• Skin abnormalities in the target area, e.g., cuts, scrapes, wounds, large moles.
• Pregnant and/or breastfeeding (Applicable to females only)
• Having an infection, dermatitis or a rash in the treatment area.
• Significant concurrent illness, such as diabetes mellitus, cardiovascular disease, e.g., uncontrolled hypertension or pertinent neurological disorders.
• Suffering from coagulation disorders or taking prescription anticoagulation medications.
• History of keloid scarring, hypertrophic scarring or of abnormal wound healing.
• History of immunosuppression/immune deficiency disorders or currently using immunosuppressive medications.
• History of vitiligo, eczema, or psoriasis.
• History of disease stimulated by heat, such as recurrent herpes simplex and/or herpes zoster (shingles) in the treatment area, unless treatment is conducted following a prophylactic regimen.
• History of radiation to the treatment area or undergoing systemic chemotherapy for the treatment of cancer.
• Current smoker or history of smoking within 6 months of study participation.
• As per the Investigator's discretion, any physical or mental condition which might make it unsafe for the subject to participate in this study